The Front Range Biological Safety Association (FRaBSA) is an official affiliate of the American Biological Safety Association (ABSA). FRaBSA was founded in 2009 for the purpose of promoting the principles of biological safety and providing a forum for dissemination of information between individuals in this and related fields.
We are looking for individuals who are interested in serving on the Front Range Biosafety Association Board in one of the following capacities:
President-Elect – This entails a 3-year commitment (1 year as President-Elect, 1 year as President, 1 year as Past-President)
Treasurer – This is a 2-year commitment
Communications Director – This is a 2-year commitment
Counselor-at-large – This is a 2-year commitment
Chair of the Outreach Committee – This is a 2-year commitment
What kind of time commitment does this require? We have monthly board meetings via teleconference, some work outside of the board meetings depending upon the issues we are addressing. In addition, you are expected to participate to the extent possible with 3 general membership meetings held during the year.
If you are interested in running or want to nominate someone else for a position, please use this link.
Any person with an interest in biological safety shall be eligible for Individual Membership. Individual Members shall be eligible to vote, to hold office, to serve on committees, and to enjoy other rights of the Association.
Any company or organization with an interest in biological safety shall be eligible for Corporate Membership. Each Corporate Member may designate up to four persons as Individual Members. Each of these four individuals shall be eligible to vote, to hold office, to serve on committees, and to enjoy other rights of the Association.
Corporate Sponsorship – Varies
Corporate sponsorships may include membership dues as well. Contact Sue Farr at firstname.lastname@example.org if you are interested in being a corporate sponsor.
FRaBSA held a COVID-19 webinar on 4-24-20. This webinar was well attended with over 300 attendees representing universities, public agencies, private companies and even a few Canadians. A recording of this webinar is available on FRaBSA’s youtube channel:
April 25, 2019, the National Institutes of Health (NIH) finalized a proposal to amend the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules (NIH Guidelines) to streamline the oversight of gene therapy research. This proposal, which was developed in conjunction with the Food and Drug Administration, included amending the NIH Guidelines to eliminate duplicative review and reporting requirements for human gene transfer protocols and refocuses the role of the NIH Recombinant DNA Advisory Committee (RAC) as a transparent forum for science, safety, and ethics of emerging biotechnologies. After a 60-day public comment period, the NIH Guidelines have been updated to reflect these changes and the RAC has been renamed the Novel and Exceptional Technology and Research Advisory Committee (NExTRAC).
note that the roles and responsibilities of Institutional Biosafety Committees
(IBCs) to review gene therapy protocols have been modified so that they are
consistent with the review of other research covered under the NIH
Guidelines. Gene therapy protocols remain subject to Food and Drug
Administration (FDA) and other clinical trial regulations, and only after FDA,
Institutional Biosafety Committee, Institutional Review Boards, and other
relevant approvals are in place can these protocols proceed.
Risk Group Database App
FREE for iTunes and Android!
ABSA International created an app for the ABSA Risk Group Database, which is available for Apple and Android devices. The app will allow users to access the ABSA Risk Group Database on their mobile devices.
The ABSA Risk Group Database consists of international risk group classifications for Bacteria, Viruses, Fungi, and Parasites. In many countries, including the United States, infectious agents are categorized in risk groups based on their relative risk. Depending on the country and/or organization, this classification system might take the following factors into consideration: pathogenicity of the organism; mode of transmission and host range; availability of effective preventive measures (e.g., vaccines); availability of effective treatment (e.g., antibiotics); and other factors.
iPhone and iPad Instructions:
You can download the Risk Group Database app in the Apple iTunes store by searching for “Risk Group Database app.”
You can download the Risk Group Database app in the Google Play Store by searching for “Risk Group Database.”
The app only works when your device is connected to the internet.
Please send any comments or suggestions about the app to email@example.com. An update is being planned for early October.
ABSA International would like to express our sincere gratitude to the fellows at the National Biosafety and Biocontainment Program (NBBTP) for updating the ABSA Risk Group Database.
Biosafety director earns acclaim for securing research pathogens | SOURCE
The Colorado State University officer charged with protecting researchers and the public from infectious research pathogens has received international honors for effective safeguards that support research success.
Bob Ellis, CSU biosafety director, earned the Everett Hanel, Jr. Presidential Award from the American Biological Safety Association for outstanding work promoting biosafety and high professional standards.